Resources
Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration
Lynn Webster, MD, Executive Vice President of Scientific Affairs, recently presented his poster titled “A Review of the ...
Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access
Our Executive Vice President of Scientific Affairs, Dr. Lynn Webster, has released a co-authored review on opioid ...